{"count": 10, "results": [{"_id": "11166784", "pmid": 11166784, "title": "Effect of simvastatin on micropulmonary red cell mass in patients with hyperlipoproteinemia.", "journal": "Atherosclerosis", "authors": ["Pintaric I", "Eterović D", "Tocilj J", "Reiner Z", "Lusić I"], "date": "2001-02-01T00:00:00Z", "doi": "10.1016/s0021-9150(00)00505-0", "meta_date_publication": "2001 Feb 1", "meta_volume": "154", "meta_issue": "2", "meta_pages": "493-6", "score": 50086.887, "text_hl": "Effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on micropulmonary red cell mass in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Hyperlipoproteinemias</m> @DISEASE_MESH:D006951 @@@hyperlipoproteinemia@@@.", "citations": {"NLM": "Pintaric I, Eterović D, Tocilj J, Reiner Z, Lusić I. Effect of simvastatin on micropulmonary red cell mass in patients with hyperlipoproteinemia. Atherosclerosis. 2001 Feb 1;154(2):493-6. PMID: 11166784", "BibTeX": "@article{11166784, title={Effect of simvastatin on micropulmonary red cell mass in patients with hyperlipoproteinemia.}, author={Pintaric I and Eterović D and Tocilj J and Reiner Z and Lusić I}, journal={Atherosclerosis}, volume={154}, number={2}, pages={493-6}}"}}, {"_id": "2149540", "pmid": 2149540, "title": "[The treatment of refractory hyperlipoproteinemias].", "journal": "Clin Ter", "authors": ["Barone A", "Ansuini R", "Francolini G", "Frausini G", "Pupita F"], "date": "1990-10-15T00:00:00Z", "meta_date_publication": "1990 Oct 15", "meta_volume": "135", "meta_issue": "1", "meta_pages": "31-6", "score": 50085.934, "text_hl": "[The treatment of refractory @<m>DISEASE_Hyperlipoproteinemias</m> @DISEASE_MESH:D006951 @@@hyperlipoproteinemias@@@].", "citations": {"NLM": "Barone A, Ansuini R, Francolini G, Frausini G, Pupita F. [The treatment of refractory hyperlipoproteinemias]. Clin Ter. 1990 Oct 15;135(1):31-6. PMID: 2149540", "BibTeX": "@article{2149540, title={[The treatment of refractory hyperlipoproteinemias].}, author={Barone A and Ansuini R and Francolini G and Frausini G and Pupita F}, journal={Clin Ter}, volume={135}, number={1}, pages={31-6}}"}}, {"_id": "10067240", "pmid": 10067240, "title": "[Variability of the hypolipidemic action of simvastatin and fluvastatin in patients with primary hyperlipoproteinemia].", "journal": "Ter Arkh", "authors": ["Tvorogova MG", "Susekov AV", "Semenova OA", "Kukharchuk VV", "Titov VN"], "date": "1998-01-01T00:00:00Z", "meta_date_publication": "1998", "meta_volume": "70", "meta_issue": "12", "meta_pages": "8-13", "score": 50080.883, "text_hl": "[Variability of the hypolipidemic action of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Fluvastatin @CHEMICAL_MESH:D000077340 @@@fluvastatin@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Hyperlipoproteinemias</m> @DISEASE_MESH:D006951 @@@primary hyperlipoproteinemia@@@].", "citations": {"NLM": "Tvorogova MG, Susekov AV, Semenova OA, Kukharchuk VV, Titov VN. [Variability of the hypolipidemic action of simvastatin and fluvastatin in patients with primary hyperlipoproteinemia]. Ter Arkh. 1998;70(12):8-13. PMID: 10067240", "BibTeX": "@article{10067240, title={[Variability of the hypolipidemic action of simvastatin and fluvastatin in patients with primary hyperlipoproteinemia].}, author={Tvorogova MG and Susekov AV and Semenova OA and Kukharchuk VV and Titov VN}, journal={Ter Arkh}, volume={70}, number={12}, pages={8-13}}"}}, {"_id": "12816176", "pmid": 12816176, "title": "Effects of fenofibrate and simvastatin on plasma sICAM-1 and MCP-1 concentrations in patients with hyperlipoproteinemia.", "journal": "Int J Clin Pharmacol Ther", "authors": ["Kowalski J", "Okopien B", "Madej A", "Zielinski M", "Belowski D", "Kalina Z", "Herman ZS"], "date": "2003-06-01T00:00:00Z", "doi": "10.5414/cpp41241", "meta_date_publication": "2003 Jun", "meta_volume": "41", "meta_issue": "6", "meta_pages": "241-7", "score": 50070.855, "text_hl": "Effects of @CHEMICAL_Fenofibrate @CHEMICAL_MESH:D011345 @@@fenofibrate@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on plasma sICAM-1 and @GENE_CCL2 @GENE_6347 @@@MCP-1@@@ concentrations in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Hyperlipoproteinemias</m> @DISEASE_MESH:D006951 @@@hyperlipoproteinemia@@@.", "citations": {"NLM": "Kowalski J, Okopien B, Madej A, Zielinski M, Belowski D, Kalina Z, Herman ZS. Effects of fenofibrate and simvastatin on plasma sICAM-1 and MCP-1 concentrations in patients with hyperlipoproteinemia. Int J Clin Pharmacol Ther. 2003 Jun;41(6):241-7. PMID: 12816176", "BibTeX": "@article{12816176, title={Effects of fenofibrate and simvastatin on plasma sICAM-1 and MCP-1 concentrations in patients with hyperlipoproteinemia.}, author={Kowalski J and Okopien B and Madej A and Zielinski M and Belowski D and Kalina Z and Herman ZS}, journal={Int J Clin Pharmacol Ther}, volume={41}, number={6}, pages={241-7}}"}}, {"_id": "12058342", "pmid": 12058342, "title": "Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia.", "journal": "Exp Clin Endocrinol Diabetes", "authors": ["Geiss HC", "Schwandt P", "Parhofer KG"], "date": "2002-06-01T00:00:00Z", "doi": "10.1055/s-2002-32150", "meta_date_publication": "2002 Jun", "meta_volume": "110", "meta_issue": "4", "meta_pages": "182-7", "score": 50068.508, "text_hl": "This suggests that the effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on LDL-subtype distribution depends on the type of underlying @<m>DISEASE_Hyperlipoproteinemias</m> @DISEASE_MESH:D006951 @@@hyperlipoproteinemia@@@.", "citations": {"NLM": "Geiss HC, Schwandt P, Parhofer KG. Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia. Exp Clin Endocrinol Diabetes. 2002 Jun;110(4):182-7. PMID: 12058342", "BibTeX": "@article{12058342, title={Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia.}, author={Geiss HC and Schwandt P and Parhofer KG}, journal={Exp Clin Endocrinol Diabetes}, volume={110}, number={4}, pages={182-7}}"}}, {"_id": "7869918", "pmid": 7869918, "title": "A comparison between the effects of gemfibrozil and simvastatin on insulin sensitivity in patients with non-insulin-dependent diabetes mellitus and hyperlipoproteinemia.", "journal": "Metabolism", "authors": ["Ohrvall M", "Lithell H", "Johansson J", "Vessby B"], "date": "1995-02-01T00:00:00Z", "doi": "10.1016/0026-0495(95)90267-8", "meta_date_publication": "1995 Feb", "meta_volume": "44", "meta_issue": "2", "meta_pages": "212-7", "score": 50068.23, "text_hl": "A comparison between the effects of @CHEMICAL_Gemfibrozil @CHEMICAL_MESH:D015248 @@@gemfibrozil@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on insulin sensitivity in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@non-insulin-dependent diabetes mellitus@@@ and @<m>DISEASE_Hyperlipoproteinemias</m> @DISEASE_MESH:D006951 @@@hyperlipoproteinemia@@@.", "citations": {"NLM": "Ohrvall M, Lithell H, Johansson J, Vessby B. A comparison between the effects of gemfibrozil and simvastatin on insulin sensitivity in patients with non-insulin-dependent diabetes mellitus and hyperlipoproteinemia. Metabolism. 1995 Feb;44(2):212-7. PMID: 7869918", "BibTeX": "@article{7869918, title={A comparison between the effects of gemfibrozil and simvastatin on insulin sensitivity in patients with non-insulin-dependent diabetes mellitus and hyperlipoproteinemia.}, author={Ohrvall M and Lithell H and Johansson J and Vessby B}, journal={Metabolism}, volume={44}, number={2}, pages={212-7}}"}}, {"_id": "18074758", "pmid": 18074758, "title": "Clinical study on the effect of simvastatin on paraoxonase activity.", "journal": "Arzneimittelforschung", "authors": ["Muacević-Katanec D", "Bradamante V", "Poljicanin T", "Reiner Z", "Babić Z", "Simeon-Rudolf V", "Katanec D"], "date": "2007-01-01T00:00:00Z", "doi": "10.1055/s-0031-1296663", "meta_date_publication": "2007", "meta_volume": "57", "meta_issue": "10", "meta_pages": "647-53", "score": 50065.613, "text_hl": "The study demonstrated a statistically significant @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ lowering effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on total and LDL cholesterol, and an increase in @GENE_PON1 @GENE_5444 @@@PON1@@@ activity in @SPECIES_9606 @@@patients@@@ with both types of @<m>DISEASE_Hyperlipoproteinemias</m> @DISEASE_MESH:D006951 @@@hyperlipoproteinemia@@@. ", "citations": {"NLM": "Muacević-Katanec D, Bradamante V, Poljicanin T, Reiner Z, Babić Z, Simeon-Rudolf V, Katanec D. Clinical study on the effect of simvastatin on paraoxonase activity. Arzneimittelforschung. 2007;57(10):647-53. PMID: 18074758", "BibTeX": "@article{18074758, title={Clinical study on the effect of simvastatin on paraoxonase activity.}, author={Muacević-Katanec D and Bradamante V and Poljicanin T and Reiner Z and Babić Z and Simeon-Rudolf V and Katanec D}, journal={Arzneimittelforschung}, volume={57}, number={10}, pages={647-53}}"}}, {"_id": "8847874", "pmid": 8847874, "title": "Multicenter comparison of micronized fenofibrate and simvastatin in patients with primary type IIA or IIB hyperlipoproteinemia.", "journal": "J Cardiovasc Pharmacol", "authors": ["Steinmetz A", "Schwartz T", "Hehnke U", "Kaffarnik H"], "date": "1996-04-01T00:00:00Z", "doi": "10.1097/00005344-199604000-00016", "meta_date_publication": "1996 Apr", "meta_volume": "27", "meta_issue": "4", "meta_pages": "563-70", "score": 50062.156, "text_hl": "Multicenter comparison of micronized @CHEMICAL_Fenofibrate @CHEMICAL_MESH:D011345 @@@fenofibrate@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in @SPECIES_9606 @@@patients@@@ with primary @DISEASE_143890 @DISEASE_OMIM:143890 @@@type IIA or IIB hyperlipoproteinemia@@@.", "citations": {"NLM": "Steinmetz A, Schwartz T, Hehnke U, Kaffarnik H. Multicenter comparison of micronized fenofibrate and simvastatin in patients with primary type IIA or IIB hyperlipoproteinemia. J Cardiovasc Pharmacol. 1996 Apr;27(4):563-70. PMID: 8847874", "BibTeX": "@article{8847874, title={Multicenter comparison of micronized fenofibrate and simvastatin in patients with primary type IIA or IIB hyperlipoproteinemia.}, author={Steinmetz A and Schwartz T and Hehnke U and Kaffarnik H}, journal={J Cardiovasc Pharmacol}, volume={27}, number={4}, pages={563-70}}"}}, {"_id": "1472833", "pmid": 1472833, "title": "The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipoproteinemia.", "journal": "Clin Investig", "authors": ["Feussner G", "Eichinger M", "Ziegler R"], "date": "1992-11-01T00:00:00Z", "doi": "10.1007/BF00180314", "meta_date_publication": "1992 Nov", "meta_volume": "70", "meta_issue": "11", "meta_pages": "1027-35", "score": 50054.434, "text_hl": "Nineteen adult @SPECIES_9606 @@@patients@@@ with @DISEASE_Hyperlipoproteinemia_Type_III @DISEASE_MESH:D006952 @@@type III hyperlipoproteinemia@@@ (@<m>DISEASE_Hyperlipoproteinemias</m> @DISEASE_MESH:D006951 @@@HLP@@@) and homozygosity for @GENE_APOE @GENE_348 @@@apolipoprotein (apo) E2@@@ were treated with the @GENE_HMGCR @GENE_3156 @@@3-hydroxy-3-methyl glutaryl coenzyme A (HMG CoA) reductase@@@ inhibitor @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (20 or 40 mg per day) alone or in combination with the @CHEMICAL_Fibric_Acids @CHEMICAL_MESH:D058607 @@@fibrate@@@ derivative @CHEMICAL_Gemfibrozil @CHEMICAL_MESH:D015248 @@@gemfibrozil@@@ (450 mg per day) during a 30-week @SPECIES_9606 @@@outpatient@@@ study. ", "citations": {"NLM": "Feussner G, Eichinger M, Ziegler R. The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipoproteinemia. Clin Investig. 1992 Nov;70(11):1027-35. PMID: 1472833", "BibTeX": "@article{1472833, title={The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipoproteinemia.}, author={Feussner G and Eichinger M and Ziegler R}, journal={Clin Investig}, volume={70}, number={11}, pages={1027-35}}"}}, {"_id": "14626567", "pmid": 14626567, "title": "[Long-term hypolipidemic treatment of mixed hyperlipidemia with a combination of statins and fibrates].", "journal": "Cas Lek Cesk", "authors": ["Zeman M", "Zák A", "Vecka M", "Romaniv S"], "date": "2003-08-01T00:00:00Z", "meta_date_publication": "2003 Aug", "meta_volume": "142", "meta_issue": "8", "meta_pages": "500-4", "score": 50046.492, "text_hl": "Aim of the study was to evaluate efficacy and safety of long-term treatment of @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@ + @CHEMICAL_Fenofibrate @CHEMICAL_MESH:D011345 @@@fenofibrate@@@ or @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ + @CHEMICAL_ciprofibrate @CHEMICAL_MESH:C019304 @@@ciprofibrate@@@ therapy in the high-risk group of @SPECIES_9606 @@@patients@@@ with severe mixed @<m>DISEASE_Hyperlipoproteinemias</m> @DISEASE_MESH:D006951 @@@hyperlipoproteinemia@@@. ", "citations": {"NLM": "Zeman M, Zák A, Vecka M, Romaniv S. [Long-term hypolipidemic treatment of mixed hyperlipidemia with a combination of statins and fibrates]. Cas Lek Cesk. 2003 Aug;142(8):500-4. PMID: 14626567", "BibTeX": "@article{14626567, title={[Long-term hypolipidemic treatment of mixed hyperlipidemia with a combination of statins and fibrates].}, author={Zeman M and Zák A and Vecka M and Romaniv S}, journal={Cas Lek Cesk}, volume={142}, number={8}, pages={500-4}}"}}]}